MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2019 International Congress

    Neuropsychiatric manifestations in Parkinson’s disease

    O. Cherkaoui Rhazouani, N. Jalami, M. Chraa, N. Kissani (Marrakech, Morocco)

    Objective: Evaluate the different neuropsychiatric manifestations in Parkinson's disease. Background: Parkinson's disease (PD) is the second most common neurodegenerative pathology after Alzheimer's disease, although PD…
  • 2019 International Congress

    Pramipexole regulates the depressive-like symptom through dopamine D3 not dopamine D2 receptor in a mouse model of Parkinson’s disease

    SZ. Wei, F. Wang, CF. Liu (Suzhou, China)

    Objective: The aim of this study is to understand if the antidepressant effect of pramipexole is mediated by D2R or D3R in a mouse model…
  • 2019 International Congress

    Pursuit of Psychosocial Intervention for Depression and Anxiety in Japanese Parkinson’s Disease patients: Two Studies of Cognitive Behavioral Therapy

    I. Shinmei, N. Nishikawa (Tokyo, Japan)

    Objective: From 2013 to the present, we have explored the feasibility of cognitive behavioral therapy (CBT) for Japanese Parkinson’s disease (PD) patients with depression and…
  • 2019 International Congress

    Study of prevalence of Axis-1 DSM-4 psychiatric disorders in patients with parkinsonism in a rural movement disorder clinic in Western India

    D. Desai, S. Singh, S. Desai (Anand, India)

    Objective: To assess the prevalence of Axis-1 DSM-4 [The Diagnostic and Statistical Manual of Mental disorders] psychiatric disorders in patients with Parkinson’s disease [PD], atypical…
  • 2019 International Congress

    The study on brain function network of Parkinson’s disease with depression

    Y. Qiu, L. Wang (Guangzhou, China)

    Objective: To investigate the topological properties and abnormal connections of the networks in Parkinson’s disease (PD) patients with depression (DPD) Background: Depression is one of…
  • 2019 International Congress

    Exploratory analysis of the relationship between pain and mood disturbances in Parkinson’s disease

    C. Vila, A. Sparks, P. Imbriani, N. Caputi, L. Covington, T. Schirinzi, S. Natoli, A. Pisani, P. Ghosh (Washington, DC, USA)

    Objective: This study aims to investigate the relationship between pain and mood disturbances in patients with Parkinson disease (PD). Background: Pain and mood disturbances are…
  • 2018 International Congress

    Application of Chinese version of SWAL-QOL in Parkinson’s Disease

    H.F. Chan, H. Kim, M. Ng, DY. Kim (Seoul, Republic of Korea)

    Objective: The aims of this study include: (1) to evaluate swallowing-related Quality of Life (QoL) in PD by using the validated Chinese version of the…
  • 2018 International Congress

    Depression (BDI-II) in Parkinson’s disease: Prevalence, types, and variables associated to major, minor and subclinical depression in COPPADIS cohort

    M. Aguilar, P. Pastor, M. Almeria, I. Alvarez, S. Arribas, I. Gonzalez, M. Sierra, J. Infante, A. Avila, M. Catalan, F. Alonso, C. Villanueva, L. Lopez, V. Nogueira, V. Puente, A. Crespo, J. Garcia, F. Damas, E. Pacheco, P. Martínez-Martin, D. Santos, G. Coppadis (Terrassa, Spain)

    Objective: To know the prevalence and characteristics of depression in PD patients of the COPPADIS-2015 cohort and its relationship with the other clinical aspects of…
  • 2018 International Congress

    Factors affecting quality of life in patients with Parkinson´s disease: Motor vs non-motor symptoms. Results from the COPPADIS Study Cohort

    D. Santos, T. de Deus, C. Borrué, M. Mata, B. Solano Vila, A. Cots Foraster, M. Álvarez Sauco, A.B. Rodríguez Pérez, L. Vela, Y. Macías, S. Escalante, P. Estebe, S. Reverté, E. Cubo, E. Casas, S. Arnaiz, F. Carrillo Padilla, M. Pueyo, P. Mir, P. Martínez Martín, G. Coppadis Study (Ferrol, Spain)

    Objective: To identify factors related to a worse health-related and global perceived quality of life (QoL) in a cohort of Parkinson´s disease (PD) patients and…
  • 2018 International Congress

    Evaluation of affective temperament and bipolarity among patients with Parkinson’ s disease

    Y. Degirmenci, K. Altinbas, H. Kececi (Duzce, Turkey)

    Objective: To compare the bipolarity and affective temperament scores between patients with Parkinson’s Disease (PD) and healthy controls. Background: Mood disorders are the most common…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley